<DOC>
	<DOCNO>NCT00231231</DOCNO>
	<brief_summary>The primary objective study ass outcomes stenting distal protection treatment obstructive carotid artery disease peri-approval/initial commercialization relation outcome Sapphire Clinical Trial . The device utilized Cordis PRECISE Nitinol Stent Systems Cordis ANGIOGUARD™ XP Emboli Capture Guidewire ( ECGW ) .</brief_summary>
	<brief_title>Carotid Artery Stenting With Emboli Protection Surveillance-Post-Marketing Study ( CASES-PMS )</brief_title>
	<detailed_description />
	<mesh_term>Carotid Artery Diseases</mesh_term>
	<criteria>1 . The patient must &gt; 18 year age . 2 . The patient 50 % stenosis ( determine ultrasound angiogram ) common internal carotid artery clinically symptomatic ; i.e. , within previous 180 day experience symptoms ipsilateral carotid artery distribution , define : one TIAs , characterize distinct focal neurologic dysfunction monocular blindness clearing sign symptom within 24 hour , one complete stroke ( define protocol ) persistence symptom sign 24 hour ( recent event use qualify event ) , except exclude , stenosis &gt; 50 % , ( determine ultrasound angiogram ) common internal carotid artery , OR The patient must &gt; 80 % diameter stenosis ( determine ultrasound angiogram ) internal common carotid artery without neurological symptom . 3 . To enter study , patient must one follow condition : · congestive heart failure ( class III/IV ) and/or know severe leave ventricular dysfunction LVEF &lt; 30 % open heart surgery within six week recent MI ( &gt; 24 hour &lt; 4 week ) unstable angina ( CCS class III/IV ) synchronous severe cardiac carotid disease require open heart surgery carotid revascularization severe pulmonary disease include follow : 1. chronic oxygen therapy 2. rest PO2 60 mmHg 3. baseline hematocrit 50 % 4 . FEV1 DLCO 50 % normal . · contralateral carotid occlusion · contralateral laryngeal palsy · postradiation treatment · previous CEA recurrent stenosis · high cervical ICA lesion · CCA lesion clavicle · severe tandem lesion abnormal stress test . 4 . The qualify ultrasound angiogram perform less 30 day prior study entry . · Stenosis &gt; 50 % : PSV &gt; 130 cm/sec ; EDV &lt; 135 cm/sec · Stenosis &gt; 80 % : PSV &gt; 220 cm/sec ; EDV &lt; 135 cm/sec · PSV ICA/PSV CCA ratio 4.0 5 . The target vessel native common internal carotid artery . The arterial segment treat diameter 4 mm 9 mm large diameter either proximal distal lesion . 1 . The patient experience acute ischemic neurologic stroke experience stroke within past 48 hour . 2 . There visual angiographic ultrasound evidence intraluminal thrombus think increase risk plaque fragmentation distal embolization . 3 . There total occlusion target carotid artery treatment site . 4 . The reference segment diameter ( distal common carotid internal carotid artery segment cephalic lesion ) less 4mm great 9mm . See Instructions For Use , proper stent sizing . The exception would lesion &gt; 95 % stenosis true diameter distal vessel determine case string sign distal vessel collapse . In case judgment interventionalist prevail intention oversize stent distal vessel 2mm . 5 . The patient intracranial aneurysm ( &gt; 9 mm ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2007</verification_date>
</DOC>